Results 11 to 20 of about 8,688 (201)

Laboratory Identification of Pseudohypercalcemia Induced by Hyperglobulinemia in Multiple Myeloma: A Case Report [PDF]

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Pseudohypercalcemia induced by calcium‐binding monoclonal immunoglobulin in multiple myeloma is verified via laboratory assays and validated by therapeutic response. ABSTRACT Background Pseudohypercalcemia is easily misdiagnosed in clinical practice, potentially leading to unnecessary interventions.
Anjiang Zhao   +3 more
wiley   +2 more sources

Hypergammaglobulinemia in treated and untreated people with HIV. [PDF]

open access: yesPLoS ONE
BackgroundB cell abnormalities are an early feature of human immunodeficiency virus-1 (HIV) infection, leading to hypergammaglobulinemia.Objective(s)The aim of this study was to evaluate serum levels of immunoglobulin G (IgG) as well as the inflammatory ...
Isabel Vigmo   +5 more
doaj   +3 more sources

Prognostic benefit of immunosuppressive agents in primary Sjögren’s syndrome patients with hypergammaglobulinemia [PDF]

open access: yesFrontiers in Immunology
ObjectiveTo elucidate the prognosis of patients with primary Sjögren’s syndrome (pSS) accompanied by hypergammaglobulinemia (HG), with a particular focus on the impact of various treatments.MethodsPatients were divided into the HG group and the non-HG ...
Liupan Zhang   +8 more
doaj   +2 more sources

Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis.

open access: yesPLoS ONE, 2019
As debate rumbles on about whether anti-hepatitis B virus (HBV) nucleos(t)ide analogue treatments modulate host immune system during end-stage liver diseases, we studied effects of two potent anti-HBV agents, telbivudine or entecavir, on humoral immune ...
Cheng-Hsun Ho   +2 more
doaj   +2 more sources

Impact of Sjögren’s disease and its immunological characteristics on reaching remission or low disease activity state in systemic lupus erythematosus patients: a propensity score-matched longitudinal study [PDF]

open access: yesFrontiers in Immunology
BackgroundSystemic lupus erythematosus (SLE) overlapping with Sjögren’s disease (SjD) or not may progress differently in the clinical course. We aimed to explore the impact of SjD on lupus low disease activity state (LLDAS) or remission achievement in a ...
Haoze Zhang   +5 more
doaj   +2 more sources

Early-onset systemic lupus erythematosus in a patient with an inborn error of immunity caused by a NRAS mutation and treated with telitacicept [PDF]

open access: yesMolecular and Cellular Pediatrics
Here, we report a female (aged 1 year and 8 months) who presented with recurrent skin lesions, hepatosplenomegaly, lymphadenopathy, and fever.
Zhijuan Kang, Liang Zhang
doaj   +2 more sources

Congenital nephrotic syndrome

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2014
CNS (Congenital nephrotic syndrome) is a disorder characterized by the presence of a nephrotic syndrome in the first three months of life. Different pathologies can cause this syndrome.
Claudia Fanni   +5 more
doaj   +1 more source

Features and outcome of AIH patients without elevation of IgG

open access: yesJHEP Reports, 2020
Background & Aims: High IgG levels are considered a hallmark of autoimmune hepatitis (AIH). A subgroup of patients with AIH has IgG within the normal range despite evidence of clinical disease activity. The clinical significance of this biomarker has
Johannes Hartl   +17 more
doaj   +1 more source

Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals [PDF]

open access: yes, 1983
The cytolytic activity ofhuman peripheral blood monocytes in vitro against K-562 human leukaemic target cells was stimulated by human fibroblast (fi-) and leucocyte (a-) interferon (IFN). Stimulation was by up to several times the corresponding control
Virelizier, JL, Dean, RT
core   +7 more sources

Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study [PDF]

open access: yes, 2014
Background: The significance of hypergammaglobulinemia as a marker of immune activation is unknown, as a differential diagnosis for hypergammaglobulinemia in children has not been adequately established.
Sundel, Robert   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy